Overview

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate efficacy and safety of HCP1301 capsule in patients with Benign Prostatic Hyperplasia and Erectile Dysfunction
Phase:
Phase 3
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited